Tactile Systems Technology Inc (TCMD) Stock Price & Analysis
Tactile Systems Technology Inc (TCMD) fell 0.96% to USD 21.66 as of September 8, 2026 at 16:58 UTC, according to Nexqual real-time market data.
TCMD last closed at USD 21.66; the session ranged USD 21.29–21.77 on volume of 101,061 shares. Market capitalization is —, with a 52-week range of USD 13.14–37.77 (NGM). Source: Nexqual, September 8, 2026 at 16:58 UTC.
Key Statistics (as of September 8, 2026 at 16:58 UTC)
| Price | USD 21.66 |
|---|---|
| Change | ▼ 0.96% (down) |
| Previous Close | USD 21.66 |
| Open | USD 21.66 |
| Day Range | USD 21.29 – 21.77 |
| 52-Week Range | USD 13.14 – 37.77 |
| Volume | 101,061 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TCMD)
Nexqual's technical model rates TCMD "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:58 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.88 (oversold) |
| vs SMA50 | Below (USD 26.82) |
| MACD | -1.36 (negative) |
From Tactile Systems Technology Inc's Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- In the United States, we and some of our manufacturers are required to manufacture our products in compliance with the FDA's Quality Management System Regulation, as updated to take effect on February 2, 2026, which covers the methods and documentation of the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping for our products.
- Our proprietary Flexitouch, Entre and Nimbl systems are clinically proven at-home solutions for patients with vascular disorders such as lymphedema.
- The patented mechanism of action of the Flexitouch Plus system works by sequentially inflating and deflating its chambers to create a gentle, wave-like motion that directs lymph fluid from the impaired areas toward healthy regions of the body.  By automating 10 Table of Contents this technique, we believe our system offers an effective, cost-efficient, convenient and accessible at-home treatment for patients.
- This model allows us to engage directly with patients and clinicians, which are both critical audiences to which we can provide clinical evidence and education.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VREX | Varex Imaging Corporation | USD 18.51 | ▼ 0.05% |
| SIBN | SI-BONE, Inc. | USD 18.53 | ▼ 0.59% |
| KIDS | OrthoPediatrics Corp. | USD 21.97 | ▼ 2.74% |
| AXGN | AxoGen, Inc. | USD 46.72 | ▼ 0.81% |
| OFIX | Orthofix Medical Inc. | USD 9.14 | ▼ 1.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:58 UTC. This page is informational and not investment advice.